BLOOD RESEARCH

pISSN 2287-979X
eISSN 2288-0011

Download original image
Fig. 3.

The event-free survival (EFS) after allogeneic hematopoietic stem cell transplantation in terms of disease status at the time of transplantation. The 5-year EFS rate was not significantly different between CR1/CR2 (N=5) and persistent disease status (N=4) (P=0.478).

Abbreviations: CR1, complete remission 1; CR2, complete remission 2.

Blood Res 2016;51:242~248 https://doi.org/10.5045/br.2016.51.4.242
© Blood Res